Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter

Use tags to find relevant records

3D printed implants

Ablation methods

Allogeneic mesenchymal stem cells

Ambulatory ECG monitoring

Aortic abdominal aneurysm

Aortic root replacement

Arthroplasty

Arthroscopy

Assisted ventilation

Atherectomy

Austria

Autologous chondrocyte implantation

Automated external defibrillator

AV fistula

AV graft

Balloon kyphoplasty

Bariatric surgery

Baroreflex activation therapy

Barrett’s oesophagus

Belgium

Benign prostatic hyperplasia

Biopsy

Bone Conductive Hearing Device

Breast reconstruction

Bronchial thermoplasty

Burns

Caesarean section

Cancer

Capsule endoscopy

Carbon ion therapy

Cardiac ablation

Cardiac computer tomography

Cardiac pacemaker

Cardiac resynchronization therapy

Cardiac Resynchronization Therapy Defibrillator (CRT-D)

Cardiovascular devices

Cardiovascular procedures

Carotid endarterectomy

Cataract

Cell therapy

Cholecystectomy

Chronic obstructive pulmonary disease

Chronic wounds

Clinical guidelines

Cochlear implants

Commissioning

Companion diagnostic tests

Computed tomography

Conditional reimbursement

Connected medical devices

Continuous glucose monitoring (CGM)

Coronary interventions

Coronary percutaneous revascularization procedures

Coronary procedures

Coronavirus

Coverage with evidence development (CED)

Embolic Protection Device

13

Mar 2023

Rapid HTAs of four medical devices released in Tuscany

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 3844 of March 02, 2023, Tuscany Regional Healthcare has published assessments of four medical devices in the cardiovascular and neurovascular treatment areas.

14

May 2019

MTRC has released European reimbursement report for use of Embolic Protection Devices during percutaneous cardiac procedures (PCI and TAVI) in 11 EU countries

The report presents a summary of reimbursement situation for use of Embolic Protection Devices during percutaneous cardiac procedures (PCI and TAVI). The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.